Provenance
SPS national PGD templates for antimicrobial treatments are created by SPS, with support from the National Institute for Health and Care Excellence (NICE), the Royal College of General Practitioners (RCGP), the Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infection (ARPHAI), UK Health Security Agency (UKHSA) and NHS England (NHSE).
PGD template attachment
Ceftriaxone for bacterial meningitis or meningococcal disease
A national PGD template for ceftriaxone for strongly suspected bacterial meningitis or strongly suspected meningococcal disease has not been developed by SPS. Further information is available via the following article:
Considerations for developing national PGD templates
Decisions to develop PGD templates under the national Medicines Governance Do Once Programme depend on a variety of factors and advice on exclusions is given.
More antimicrobial PGDs
- Clarithromycin for sinusitis
- Aciclovir for shingles
- Clarithromycin for otitis media
- Clarithromycin for infected insect bites or stings
- Fusidic acid 2% cream for impetigo
- Fluticasone furoate nasal spray for sinusitis
- Otigo (phenazone with lidocaine) ear drops for otitis media
- Penicillin V (phenoxymethylpenicillin) for sinusitis
- Erythromycin for infected insect bites or stings
- Amoxicillin for otitis media
- Clarithromycin for impetigo
- Erythromycin for sore throat
- Flucloxacillin for infected insect bites or stings
- Flucloxacillin for impetigo
- Hydrogen peroxide 1% cream for impetigo
- Erythromycin for otitis media
- Doxycycline for sinusitis
- Mometasone furoate monohydrate nasal spray for sinusitis
- Valaciclovir for shingles
- Erythromycin for sinusitis
All PGD templates
Templates
National PGD templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.
Update history
- Updated PGD template in line with updated NICE guidance NG240
- Anticipated publication date of NICE guidance updated from February 2024 to March 2024
- Expired template V1.1 removed - wording updated re anticipated publication of Version 2.0 pending updated NICE guidance publication.
- Page wording updated
- Revised wording regarding ceftriaxone
- Advisory text added regarding anticipated updated NICE guidance/impact on release of updated PGD templates.
- Title, URL and summary amended.
- Updated PGD template - expiry extended by 12 months to a total of 3 years.
- Published